This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Université Paul Sabatier (Toulouse III), Valorisation-Recherche, Limited Partnership. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 162 
1 out of 43 Years Active: 2008
Title: The Innovative Contributions of Laurent Azema
Introduction
Laurent Azema is a notable inventor based in Auterive, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications in cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Laurent Azema holds a patent for "Aldolase-inhibiting aromatic compounds." This invention relates to novel aldolase-inhibiting compounds that can be advantageously used as medicaments, especially for treating certain cancers, due to their inhibition efficacy. The inventive compound corresponds to a general formula wherein the aldehyde group (—CHO) and the phenol group (—OH) are linked to two carbon atoms adjacent to the same aromatic chain. Additionally, R is a phosphate group or a phosphate group mimetic linked to a carbon atom of a second aromatic chain. This patent highlights Azema's commitment to developing effective treatments for serious health conditions.
Career Highlights
Throughout his career, Laurent Azema has worked with various organizations that have contributed to his professional growth. Notably, he has been associated with Valorisation-Recherche, Limited Partnership, and Université Paul Sabatier (Toulouse III). His experiences in these institutions have allowed him to collaborate with other experts in the field and enhance his research capabilities.
Collaborations
Laurent Azema has collaborated with notable colleagues such as Jurgen Sygusch and Casimir Blonski. These partnerships have played a crucial role in advancing his research and expanding the impact of his inventions.
Conclusion
In summary, Laurent Azema is a distinguished inventor whose work in developing aldolase-inhibiting compounds demonstrates his significant contributions to medicinal chemistry. His innovative approach to cancer treatment reflects his dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile